Established in 1994, Tabuk Pharmaceuticals is one of the largest privately-owned pharmaceutical companies in Saudi Arabia, with a presence throughout MENA. The company develops, manufactures, markets, and distributes various pharmaceutical products from its four manufacturing sites in Saudi Arabia, Sudan, and Algeria. It has a production capacity of over two billion base units annually, serving 17 countries. It employs more than 2,400 people. In December 2021, the company signed a partnership agreement with Hansoh Pharma for the exclusive rights to manufacture and commercialize several oncology and specialty products in Saudi Arabia and other Middle East markets.